Antibodies Against Cerebral M1 Cholinergic Muscarinic Receptor from Schizophrenic Patients: Molecular Interaction1

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Journal of Immunology

• Publication date

  2002-04-01

• Fields of study

  Medicine, Chemistry, Psychology

• Identifiers
  DOI 10.4049/jimmunol.168.7.3667PMID 11907133
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Diagnostic and Statistical Manual of Mental Disorders (DSM-IV)

  2003cited by this paper
• Circulating antibodies to guanosine in systemic lupus erythematosus: correlation with nephritis and polyserositis by acute and longitudinal analyses

  2001cited by this paper
• Immunoglobulin binding to brain in autoimmune mice.

  2001cited by this paper
• The Immune System and Schizophrenia: An Integrative View

  2000influential reference
• Decreased muscarinic receptor binding in subjects with schizophrenia: a study of the human hippocampal formation.

  2000cited by this paper
• A longitudinal study of autoantibodies against central nervous system tissue and gangliosides in connective tissue diseases

  2000cited by this paper
• Potential role of muscarinic receptors in schizophrenia.

  1999cited by this paper
• Cholinergic aspects of schizophrenia

  1999cited by this paper
• The binding of [3H]AF-DX 384 is reduced in the caudate-putamen of subjects with schizophrenia.

  1999cited by this paper
• Sjögren autoantibodies modify neonatal cardiac function via M1 muscarinic acetylcholine receptor activation.

  1999cited by this paper
• Effects of Clozapine on In Vitro Immune Parameters: A Longitudinal Study in Clozapine-Treated Schizophrenic Patients

  1998cited by this paper
• Autoantibodies against 60-kDa heat shock protein in schizophrenia

  1998cited by this paper
• Involvement of endogenous nitric oxide signalling system in brain muscarinic acetylcholine receptor activation

  1998cited by this paper
• Immunological alterations in psychiatric diseases

  1997cited by this paper
• Is There an Immunopathology of the Serotonergic Synapse in Mental Disorder

  1997cited by this paper
• Interaction of human chagasic IgG with the second extracellular loop of the human heart muscarinic acetylcholine receptor: functional and pathological implications

  1997cited by this paper
• In vivo immunomodulatory effects of clozapine in schizophrenia.

  1997cited by this paper
• Autoantibodies--diagnostic, pathogenic and prognostic relevance.

  1997cited by this paper
• Muscarinic acetylcholine receptor expression in memory circuits: implications for treatment of Alzheimer disease.

  1996cited by this paper
• The density of muscarinic M1 receptors is decreased in the caudate-putamen of subjects with schizophrenia.

  1996cited by this paper
• Differential Regulation of Molecular Subtypes of Muscarinic Receptors in Alzheimer's Disease

  1995cited by this paper
• Obstetric complications and autoantibodies in schizophrenia

  1995cited by this paper
• Clozapine is a potent and selective muscarinic M4 receptor agonist.

  1994cited by this paper
• Schizophrenia and autoimmunity--a possible etiological mechanism?

  1994cited by this paper
• An association between anti-hippocampal antibody concentration and lymphocyte production of IL-2 in patients with schizophrenia

  1994cited by this paper
• Increased prevalence of antibrain antibodies in the sera from schizophrenic patients.

  1994cited by this paper
• Localization of a functional autoimmune epitope on the muscarinic acetylcholine receptor-2 in patients with idiopathic dilated cardiomyopathy.

  1993cited by this paper
• Antibodies to brain tissue in sera of schizophrenic patients

  1993cited by this paper
• Differential cholinergic innervation within functional subdivisions of the human cerebral cortex: A choline acetyltransferase study

  1992cited by this paper
• Phenotypical characterization of the rat striatal neurons expressing muscarinic receptor genes

  1992cited by this paper
• Autoantibodies to brain and polynucleotides in patients with schizophrenia: A puzzle

  1992cited by this paper
• Anticerebral antibodies in functional psychoses.

  1991cited by this paper
• Elevated IGG and IGM anticardiolipin antibodies in a subgroup of medicated and unmedicated schizophrenic patients.

  1991cited by this paper
• Platelet autoantibodies in dementia and schizophrenia. Possible implication for mental disorders.

  1991cited by this paper
• Muscarinic cholinergic hyperactivity in schizophrenia. Relationship to positive and negative symptoms.

  1991cited by this paper
• Neuroleptic binding to muscarinic M2 receptors of normal human heart in vitro and comparison with binding to M1 and dopamine D2 receptors of brain.

  1991cited by this paper
• Clozapine is a potent and selective muscarinic antagonist at the five cloned human muscarinic acetylcholine receptors expressed in CHO-K1 cells.

  1991cited by this paper
• Platelet Autoantibodies in Dementia and Schizophrenia

  1991cited by this paper
• Expression of muscarinic acetylcholine and dopamine receptor mRNAs in rat basal ganglia.

  1990cited by this paper
• Antiseptal brain antibody in IgG of schizophrenic patients.

  1989cited by this paper
• Cholinergic hyperactivity and negative schizophrenic symptoms. A model of cholinergic/dopaminergic interactions in schizophrenia.

  1989cited by this paper
• Clinical and Laboratory Evidence of Autoimmunity in Acute Schizophrenia

  1987cited by this paper
• Are there antibodies against brain in sera from schizophrenic patients? Review and prospectus.

  1985cited by this paper
• Poor interrater reliability of MECTA EEG seizure duration measurement during ECT.

  1985cited by this paper
• Antipsychotic drugs, neurotransmitters, and schizophrenia.

  1978cited by this paper
• Isolation of pure IgG1, IgG2a and IgG2b immunoglobulins from mouse serum using protein A-sepharose.

  1978cited by this paper
• Schizophrenia as an immunologic disorder. II. Effects of serum protein fractions on brain function.

  1967cited by this paper
• Schizophrenia as an Immunologic Disorder: II. Effects of Serum Protein Fractions on Brain Function

  1967cited by this paper
• The Brief Psychiatric Rating Scale

  1962influential reference

• Advancing research on regulatory autoantibodies targeting GPCRs: Insights from the 5th international symposium.

  2025cites this paper
• G protein-coupled receptors in neurodegenerative diseases and psychiatric disorders

  2023cites this paper
• Skewing of the antibody repertoire in cerebrospinal fluid B cells from healthy controls and patients with schizophrenia

  2022cites this paper
• Autoantibodies and Cardiomyopathy: Focus on Beta-1 Adrenergic Receptor Autoantibodies

  2022cites this paper
• Autoanticorps dans la myasthénie auto-immune et autoanticorps anti-récepteurs cholinergiques

  2021cites this paper
• Is there a role for antibodies targeting muscarinic acetylcholine receptors in the pathogenesis of schizophrenia?

  2019influential citation
• The link between schizophrenia and hypothyroidism: a population-based study

  2018cites this paper
• Antibodies to extracellular regions of G protein-coupled receptors and receptor tyrosine kinases as one of the causes of autoimmune diseases

  2017cites this paper
• Autoantibodies in Neuropsychiatric Disorders

  2016cites this paper
• Immune system and glucose metabolism interaction in schizophrenia: a chicken-egg dilemma.

  2014cites this paper
• Elevated levels of autoantibodies targeting the M1 muscarinic acetylcholine receptor and neurofilament medium in sera from subgroups of patients with schizophrenia.

  2014influential citation
• The Neuroimmunology of Schizophrenia

  2013cites this paper
• Increased prevalence of diverse N-methyl-D-aspartate glutamate receptor antibodies in patients with an initial diagnosis of schizophrenia: specific relevance of IgG NR1a antibodies for distinction from N-methyl-D-aspartate glutamate receptor encephalitis.

  2013cites this paper
• Autoantibodies to neurotransmitter receptors and ion channels: from neuromuscular to neuropsychiatric disorders

  2013cites this paper
• Schizophrenia is a TH2 dominant autoimmune disease possibly against acetylcholine receptors of CNS

  2012cites this paper
• Bridging the gap between the immune and glutamate hypotheses of schizophrenia and major depression: Potential role of glial NMDA receptor modulators and impaired blood–brain barrier integrity

  2012cites this paper
• Different distribution patterns of lymphocytes and microglia in the hippocampus of patients with residual versus paranoid schizophrenia: further evidence for disease course-related immune alterations?

  2012cites this paper
• Clinical psychoneuroimmunology.

  2012cites this paper
• Reduction of [11C](+)3-MPB Binding in Brain of Chronic Fatigue Syndrome with Serum Autoantibody against Muscarinic Cholinergic Receptor

  2012cites this paper
• Autoanticorps antirécepteurs cholinergiques

  2012cites this paper
• Psychotropic effects of antimicrobials and immune modulation by psychotropics: implications for neuroimmune disorders.

  2012cites this paper
• Schizophrenia and autoimmune disorders: is there a link ?

  2012cites this paper
• Muscarinic Acetylcholine Receptor Subtypes as Potential Drug Targets for the Treatment of Schizophrenia, Drug Abuse and Parkinson's Disease.

  2012cites this paper
• Modulation of prepulse inhibition through both M1 and M4 muscarinic receptors in mice

  2010cites this paper
• Acute schizophrenia is accompanied by reduced T cell and increased B cell immunity

  2010cites this paper
• Autoantibodies from schizophrenia patients induce cerebral cox-1/iNOS mRNA expression with NO/PGE2/MMP-3 production.

  2010cites this paper
• 100 B in schizophrenia : an update

  2010cites this paper
• S100B in schizophrenia: an update.

  2009cites this paper
• Treatment of schizophrenia in the 21st Century: beyond the neurotransmitter hypothesis

  2009cites this paper
• Brain abnormalities in schizophrenia

  2009cites this paper
• Viruses and Psychiatric Disorders

  2009cites this paper
• Autoimmunity and Brain Dysfunction

  2009cites this paper
• Autoantibodies to beta1-adrenoceptors in human chronic periodontitis induce overexpression of fibroblast CD40 and trigger prostaglandin E2 generation.

  2009cites this paper
• Decreased M1 muscarinic receptor density in rat amphetamine model of schizophrenia is normalized by clozapine, but not haloperidol

  2008cites this paper
• Autoantibody-mediated neuroinflammation: pathogenesis of neuropsychiatric systemic lupus erythematosus in the NZM88 murine model.

  2008cites this paper
• The Neuroimmunological Basis of Behavior and Mental Disorders

  2008cites this paper
• The Case for Autoimmunity in the Etiology of Schizophrenia

  2008cites this paper
• CHAPTER 27 – Schizophrenia and Immunity

  2007cites this paper
• Towards a muscarinic hypothesis of schizophrenia

  2007cites this paper
• Cholinergic circuits and signaling in the pathophysiology of schizophrenia.

  2007cites this paper
• The effects of maternal inflammation on neuronal development: possible mechanisms

  2007cites this paper
• ESTUDIO DE LA FUNCIÓN INMUNITARIA EN PACIENTES ESQUIZOFRÉNICOS Y BIPOLARES TIPO I

  2007cites this paper
• Regulation of m1 muscarinic receptors and nNOS mRNA levels by autoantibodies from schizophrenic patients.

  2006cites this paper
• Distribution of HLA-DR-positive microglia in schizophrenia reflects impaired cerebral lateralization

  2006cites this paper
• Bipolar Disorder: not only in the Brain - immunological aspects

  2006cites this paper
• Autoanticorps antircepteurs etautoanticorps anticanaux transmembranaires. Partie 2

  2006cites this paper
• Xanomeline and the antipsychotic potential of muscarinic receptor subtype selective agonists.

  2006cites this paper
• [Antireceptor and antichannel autoantibodies].

  2006cites this paper
• Autoantibodies associated with psychiatric disorders.

  2006cites this paper
• [Neuroimmunologic aspects of functional-somatic syndromes].

  2005cites this paper
• Autoantibodies against Submandibular Gland Muscarinic Cholinoceptor Subtypes in Primary Sjögren Syndrome

  2005cites this paper
• Immune dysregulation and self‐reactivity in schizophrenia: Do some cases of schizophrenia have an autoimmune basis?

  2005cites this paper
• Neuroimmunologische Aspekte funktioneller somatischer Syndrome

  2005cites this paper
• A high prevalence of organ-specific autoimmunity in patients with bipolar disorder.

  2004cites this paper
• Donepezil augmentation of clozapine monotherapy in schizophrenia patients: a double blind cross‐over study

  2004cites this paper
• Human mAChR antibodies from Sjögren syndrome sera increase cerebral nitric oxide synthase activity and nitric oxide synthase mRNA level.

  2004cites this paper
• Autoantibodies against cerebral muscarinic cholinoceptors in Sjögren syndrome: functional and pathological implications.

  2004cites this paper
• Antibodies against astrocyte M1 and M2 muscarinic cholinoceptor from schizophrenic patients' sera

  2004influential citation
• Antibodies From Preeclamptic Patients Stimulate Increased Intracellular Ca2+ Mobilization Through Angiotensin Receptor Activation

  2004cites this paper
• Inflammatory disorders of the central nervous system.

  2003cites this paper
• Autoantibodies against four kinds of neurotransmitter receptors in psychiatric disorders.

  2003cites this paper
• Autoantibodies against muscarinic cholinergic receptor in chronic fatigue syndrome.

  2003cites this paper
• Anti-mu-opioid-receptor IgG antibodies are commonly present in serum from healthy blood donors: evidence for a role in apoptotic immune cell death.

  2002cites this paper
• Autoimmunity to glutamate receptors in the central nervous system.

  2002cites this paper